# Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two Drugs

> **NCT01228643** · PHASE3 · WITHDRAWN · sponsor: **Azidus Brasil**

## Conditions studied

- Chronic Renal Failure

## Interventions

- **BIOLOGICAL:** Pancreatic enzimes
- **DEVICE:** Creon ®

## Key facts

- **NCT ID:** NCT01228643
- **Lead sponsor:** Azidus Brasil
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2007-06
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2022-11-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01228643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01228643, "Effectiveness of Pancreatic Enzymes in Patients Pancreatic Insufficient: Comparison of Two Drugs". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01228643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*